找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Oral Pharmacotherapy for Male Sexual Dysfunction; A Guide to Clinical Gregory A. Broderick Book 2005 Humana Press 2005 Internist.assessmen

[復(fù)制鏈接]
樓主: Coenzyme
41#
發(fā)表于 2025-3-28 14:56:57 | 只看該作者
Physiology and Pharmacology of Erectile Dysfunction,al-generated NO, in that the latter essentially helps in maintaining penile erection. Moreover, the role of endothelium in regulating smooth muscle tone and the intercellular link by means of gap junctions have also been uncovered. More recently, research has shown that changes to the downstream sig
42#
發(fā)表于 2025-3-28 19:00:16 | 只看該作者
43#
發(fā)表于 2025-3-28 22:55:26 | 只看該作者
44#
發(fā)表于 2025-3-29 06:51:19 | 只看該作者
45#
發(fā)表于 2025-3-29 07:28:14 | 只看該作者
When to Refer the Patient With Erectile Dysfunction to a Specialist,gists. Now, as primary care physicians have become increasingly sophisticated in their knowledge of ED, they, along with their nurse practitioners and physician’s assistants, account for about two-thirds of prescriptions written for phosphodiesterase (PDE) inhibitors.
46#
發(fā)表于 2025-3-29 12:11:31 | 只看該作者
47#
發(fā)表于 2025-3-29 16:25:32 | 只看該作者
48#
發(fā)表于 2025-3-29 19:52:40 | 只看該作者
Vardenafil Clinical Trials Experience,ostheses, as first-line therapy in the majority of men seeking treatment for ED. The first of these PDE5 inhibitors was sildenafil (Viagra?). In spite of the benefits of sildenafil, its ocular effect, which manifests as dose-related changes in blue-tinted vision in some patients, reflects its weak inhibition of PDE6 and lack of selectivity.
49#
發(fā)表于 2025-3-30 03:37:54 | 只看該作者
Is Diabetic Erectile Dysfunction More Difficult to Treat?,ed by ED, compared with approx 50% in an unselected population in the Massachusetts Aging Male Survey (.,.). In another cohort of patients who had type 1 diabetes for at least 10 yr, ED was reported in 1.1% of men aged 21 to 30 yr, 55% of men aged 50 to 60 yr, and 75% of men older than 60 yr (.).
50#
發(fā)表于 2025-3-30 06:29:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 10:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
乌拉特后旗| 安远县| 马鞍山市| 丹阳市| 东光县| 许昌市| 芦溪县| 河南省| 东明县| 卢氏县| 义马市| 容城县| 德格县| 轮台县| 京山县| 龙井市| 石河子市| 皋兰县| 南江县| 项城市| 东阳市| 青铜峡市| 泊头市| 长乐市| 封丘县| 都安| 五莲县| 永宁县| 九江县| 宁国市| 新龙县| 承德县| 寿光市| 旬阳县| 磐安县| 呼伦贝尔市| 呼图壁县| 定边县| 吴旗县| 新闻| 松溪县|